Cost Effectiveness Analysis of Peripheral Arterial Disease Screening With the Ankle-Brachial Index Test

被引:0
作者
Itoga, Nathan K. [1 ]
Minami, Hataka [1 ]
Chelvakumar, Meena [1 ]
Pearson, Keon [1 ]
Mell, Matthew W. [1 ]
Bendavid, Eran [1 ]
Owens, Douglas K. [1 ]
机构
[1] Stanford Univ, Stanford, CA 94305 USA
关键词
Cost-effectiveness; Peripheral artery disease (PAD); Prevention;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
322
引用
收藏
页数:2
相关论文
共 50 条
[21]   Prevalence of Abnormal Ankle-Brachial Index Among Individuals With Low or Intermediate Framingham Risk Scores [J].
Dhangana, Rajoo ;
Murphy, Timothy P. ;
Coll, Joseph R. ;
Ahn, Sun H. ;
Zafar, Abdul M. ;
Qadeer, Fathima F. ;
Hiatt, William R. .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 22 (08) :1077-1082
[22]   Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands [J].
Spoorendonk, J. A. ;
Briere, J-B ;
Bowrin, K. ;
Millier, A. ;
Coppens, M. ;
Tempelaar, S. ;
Verheggen, B. .
JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) :1231-1239
[23]   Screening for peripheral occlusive arterial disease [J].
Diehm, C. ;
Lawall, H. ;
Pittrow, D. .
GEFASSCHIRURGIE, 2009, 14 (05) :370-+
[24]   Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy [J].
Rodriguez-Sanchez, B. ;
Pena-Longobardo, L. M. ;
Sinclair, A. J. .
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2020, 21 (03) :335-349
[25]   Cost-effectiveness of chronic kidney disease mass screening test in Japan [J].
Masahide Kondo ;
Kunihiro Yamagata ;
Shu-Ling Hoshi ;
Chie Saito ;
Koichi Asahi ;
Toshiki Moriyama ;
Kazuhiko Tsuruya ;
Hideaki Yoshida ;
Kunitoshi Iseki ;
Tsuyoshi Watanabe .
Clinical and Experimental Nephrology, 2012, 16 :279-291
[26]   Peripheral arterial disease Screening in general practice [J].
Haigh, Kate ;
Bingley, John ;
Golledge, Jonathan ;
Walker, Philip J. .
AUSTRALIAN FAMILY PHYSICIAN, 2013, 42 (06) :391-395
[27]   Routine Ankle-Brachial Index (ABI) measurement: a window into atherosclerosis and early left ventricular dysfunction in patients diagnosed with cancer [J].
Golan, Netanel ;
Brzezinski, Rafael Y. ;
Slieman, Moaad ;
Khoury, Shafik ;
Havakuk, Ofer ;
Topilsky, Yan ;
Banai, Shmuel ;
Laufer-Perl, Michal .
CARDIO-ONCOLOGY, 2024, 10 (01)
[28]   Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease [J].
Treesak, C ;
Kasemsup, V ;
Treat-Jacobson, D ;
Nyman, JA ;
Hirsch, AT .
VASCULAR MEDICINE, 2004, 9 (04) :279-285
[29]   Cost-effectiveness of Diagnostic Tools to Establish the Presence of Peripheral Arterial Disease in People With Diabetes [J].
Normahani, Pasha ;
Epstein, David M. ;
Gaggero, Alessio ;
Davies, Alun H. ;
Sounderajah, Viknesh ;
Jaffer, Usman .
ANNALS OF SURGERY, 2023, 277 (01) :E184-E191
[30]   Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women [J].
Cortesi, Paolo Angelo ;
Maloberti, Alessandro ;
Micale, Mariangela ;
Pagliarin, Federica ;
Antonazzo, Ippazio Cosimo ;
Mazzaglia, Giampiero ;
Giannattasio, Cristina ;
Mantovani, Lorenzo Giovanni .
ATHEROSCLEROSIS, 2021, 317 :59-66